What is the appropriate intravenous metronidazole dose for a pediatric patient weighing 25 kg?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Metronidazole IV Dosing for a 25 kg Pediatric Patient

For a 25 kg pediatric patient requiring IV metronidazole, administer 7.5 mg/kg/dose (approximately 187.5 mg) three times daily (every 8 hours), with a maximum dose of 500 mg per dose. 1

Standard Dosing Regimen

The FDA-approved dosing for pediatric patients follows this protocol: 1

  • Loading dose: 15 mg/kg infused over one hour (375 mg for this 25 kg patient)
  • Maintenance dose: 7.5 mg/kg infused over one hour every 6 hours (187.5 mg for this 25 kg patient)
  • Maximum dose: Do not exceed 500 mg per dose
  • First maintenance dose timing: Begin 6 hours after initiating the loading dose 1

Clinical Context Considerations

For Severe/Fulminant C. difficile Infection

If treating severe or fulminant Clostridium difficile infection with critical illness, IV metronidazole should be dosed at 10 mg/kg/dose three times daily (every 8 hours), with a maximum of 500 mg per dose. 2 This translates to 250 mg every 8 hours for this 25 kg patient. However, oral vancomycin is the preferred agent for severe CDI in children, with IV metronidazole reserved only as adjunctive therapy when ileus is present. 2

For General Anaerobic Infections

For most anaerobic infections in children, the dosing varies by indication: 3

  • IV therapy: 30 mg/kg/day divided into doses (typically given as 7.5 mg/kg every 6 hours) 3
  • Oral therapy (when transitioning): 40-50 mg/kg/day divided into doses 3

Important Dosing Nuances

Recent pharmacokinetic data supports less frequent dosing in certain populations. A 2019 study demonstrated that once-daily dosing of 30 mg/kg achieved appropriate AUC/MIC ratios for Bacteroides fragilis in pediatric appendicitis patients, suggesting that more frequent dosing may not provide pharmacodynamic advantages. 4 However, this approach is not yet standard practice and the FDA label remains the authoritative source for general use. 1

Administration Guidelines

  • Infusion rate: Administer as a slow IV infusion over one hour 1
  • Do NOT use aluminum-containing equipment (needles, cannulae) as it contacts the drug solution 1
  • No dilution required: Metronidazole injection is ready-to-use and isotonic 1
  • Do not refrigerate the solution 1

Critical Safety Considerations

Avoid prolonged or repeated courses due to risk of cumulative and potentially irreversible neurotoxicity. 2 This is particularly important in pediatric patients where monitoring for neurological adverse effects should be maintained throughout therapy.

For patients with hepatic impairment, doses should be reduced and plasma levels monitored, as metronidazole metabolism is significantly impaired. 1 In neonates and young infants, the elimination half-life is substantially prolonged (up to 23.4 hours), which may necessitate dosing adjustments. 5

Duration of Therapy

Standard treatment duration is 7-10 days for most infections, though bone/joint infections, lower respiratory tract infections, and endocarditis may require longer courses. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Treatment of anaerobic infections in children with metronidazole.

Developmental pharmacology and therapeutics, 1983

Research

Intravenous metronidazole in the newborn.

Archives of disease in childhood, 1983

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.